Delivery Order SPE2DB25D3001-SPE2DB25FQUQB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Everolimus 0.75 mg tablets (60-count) with a ceiling value of $6,624.37. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 11, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a child order under a larger vehicle and carries no set-aside designation. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) under a firm fixed-price contract valued at $10,949.64. This delivery order, which is a child award under AmerisourceBergen's broader contract vehicle, represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Everolimus 5 mg tablets in quantities of 30 units, with a ceiling value of $19,375.40. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion on July 23, 2025, with performance being executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,856.17 to AmerisourceBergen Drug Corp for the supply of Everolimus 1 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order carries an ultimate completion date of August 12, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a $3,978.63 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 31, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a $17,318.52 delivery order to AmerisourceBergen Drug Corp for Everolimus 1 mg tablets (60 count) on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Everolimus 1 mg tablets (60-count) with a ceiling value of $16,540.67. This firm fixed-price delivery order is not set-aside and represents a competitive award to the prime contractor. The contract is set to be completed by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Everolimus 0.25 mg tablets (60-count unit) with a ceiling value of $10,068.17. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Everolimus 5 mg tablets (30-count packages) with a ceiling value of $44,765.09. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 13, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $39,614.76 to AmerisourceBergen Drug Corp for the supply of Everolimus 10 mg tablets (30-count units). This firm fixed price contract, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQUQBDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Everolimus 0.75 mg tablets (60-count units) with a contract value of $7,139.43. This firm fixed-price delivery order, issued on May 27, 2025, with an ultimate completion date of May 28, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competed delivery order under AmerisourceBergen's existing contract vehicle with the Defense Logistics Agency. This delivery order is executed under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies critical medications and medical commodities to support military healthcare systems and other federal agencies. The Everolimus supply aligns with the company's extensive portfolio of pharmaceutical products delivered through the DLA Medical Supply Chain, which includes specialty medications, brand-name and generic drugs, and other specialized medical supplies across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 5/27/25 |